◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
益方生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
+Revenue 169.0M 186.0M -- -- --
Revenue Growth % -9.1% -- -- -- --
Total Revenue 169.0M 186.0M 0.00 0.00 0.00
Cost Of Revenue 3.9M -- -- -- --
+Gross Profit 165.1M -- -- -- --
Gross Margin % 97.7% -- -- -- --
Total Operating Cost 419.0M 479.0M 483.0M 363.0M 1.1B
Admin Expenses 52.5M 60.9M 58.0M 47.7M 21.0M
Rd Expenses 384.0M 443.0M 461.0M 315.0M 1.0B
Finance Expenses -30.8M -34.0M -36.1M -78,100 26.9M
+Operating Income -240.0M -284.0M -483.0M -358.0M -1.1B
Operating Margin % -142.0% -152.7% -- -- --
Non Operating Expenses -- -- 179,500 -- --
Investment Income -- 6.6M -- -- 164,100
Fair Value Change Income 1.3M -- -- -- 171,100
Asset Disposal Income 75,000 -- -- 300.00 --
Asset Impairment Loss -- -- -- -- --
Other Income 8.6M 3.1M 109,200 4.9M 2.3M
Income Before Tax -240.0M -284.0M -483.0M -358.0M -1.1B
+Net Income -240.0M -284.0M -483.0M -358.0M -1.1B
Net Margin % -142.0% -152.7% -- -- --
Net Income Attributable -240.0M -284.0M -483.0M -358.0M -1.1B
Eps Basic -0.42 -0.49 -0.95 -0.78 -2.29
Eps Diluted -0.42 -0.49 -0.95 -0.78 -2.29
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash And Equivalents 1.6B 1.9B 2.2B 724.0M 1.0B
Trading Financial Assets 101.0M -- -- -- --
Accounts Receivable 165.0M 177.0M -- -- --
Notes And Accounts Receivable 165.0M 177.0M -- -- --
Prepayments 11.7M 20.5M 26.3M 3.7M 1.7M
Total Current Assets 1.9B 2.1B 2.3B 741.0M 1.0B
Fixed Assets -- 18.2M 18.5M 19.9M 5.1M
Fixed Assets Total 13.2M 18.2M 18.5M 19.9M 5.1M
Construction In Progress -- 500,000 2.6M 1.9M 3.9M
Construction In Progress Total 6.5M 500,000 2.6M 1.9M 3.9M
Intangible Assets 591,900 920,500 1.2M 114,100 --
Long Term Deferred Expenses -- 1.0M 4.4M 8.4M 3.2M
Total Non Current Assets 50.7M 39.2M 82.4M 58.6M 18.2M
Total Assets 1.9B 2.2B 2.3B 800.0M 1.1B
Accounts Payable 60.0M 72.5M 62.3M 64.2M 30.6M
Contract Liabilities -- 47.2M -- -- --
Total Current Liabilities 90.0M 158.0M 111.0M 98.9M 45.9M
Total Non Current Liabilities 20.1M 6.4M 21.9M 16.1M 800,000
Total Liabilities 110.0M 165.0M 133.0M 115.0M 46.7M
Paid In Capital 577.0M 575.0M 575.0M 460.0M 460.0M
Capital Reserve 3.8B 3.7B 3.7B 1.8B 1.7B
Retained Earnings -2.5B -2.3B -2.0B -1.5B -1.2B
Equity Attributable 1.8B 2.0B 2.2B 685.0M 1.0B
Total Equity 1.8B 2.0B 2.2B 685.0M 1.0B
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020
Cash From Sales 131.0M 50.0M -- -- --
Tax Refunds Received 8.1M 27.6M 7.9M 10.3M --
Total Operating Cash Inflow 156.0M 111.0M 29.1M 30.3M 5.6M
Cash Paid For Goods 255.0M 249.0M 363.0M 181.0M 147.0M
Cash Paid To Employees 131.0M 148.0M 115.0M 75.9M 37.8M
Taxes Paid 556,800 523,300 118,300 38,200 268,700
Total Operating Cash Outflow 398.0M 419.0M 506.0M 282.0M 203.0M
Operating Cash Flow -242.0M -308.0M -477.0M -252.0M -197.0M
Total Investing Cash Inflow 721.0M 507.0M -- -- 121.0M
Total Investing Cash Outflow 775.0M 1.2B 7.7M 26.5M 117.0M
Investing Cash Flow -53.9M -699.0M -7.7M -26.5M 3.7M
Cash From Borrowings -- 16.3M -- -- --
Dividends And Interest Paid -- 182,900 -- -- --
Debt Repayments -- 16.3M -- -- --
Total Financing Cash Inflow 7.6M 16.3M 2.0B -- 1.3B
Total Financing Cash Outflow 14.1M 29.9M 26.0M 15.9M 77.9M
Financing Cash Flow -6.5M -13.6M 2.0B -15.9M 1.2B
Net Change In Cash -302.0M -1.0B 1.5B -308.0M 1.0B
Ending Cash Balance 914.0M 1.2B 2.2B 724.0M 1.0B
Capex 7.6M 6.3M 7.7M 26.5M 5.6M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...